IL119647A - Crystalline modification v of the hydrochloride of (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl}-chroman, its preparation and a pharmaceutical composition containing it - Google Patents

Crystalline modification v of the hydrochloride of (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl}-chroman, its preparation and a pharmaceutical composition containing it

Info

Publication number: IL119647A
Authority: IL; Israel
Prior art keywords: benzisothiazol; dioxido; chroman; aminomethyl; dihydro
Prior art date: 1995-11-22

Application number

IL11964796A

Other languages

English (en)

Other versions

IL119647A0 (en

Original Assignee

Bayer Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-11-22

Filing date

1996-11-19

Publication date

1999-12-22

1996-11-19 Application filed by Bayer Ag filed Critical Bayer Ag

1997-02-18 Publication of IL119647A0 publication Critical patent/IL119647A0/xx

1999-12-22 Publication of IL119647A publication Critical patent/IL119647A/xx

Links

VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title 1
230000004048 modification Effects 0.000 title 1
238000012986 modification Methods 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Thiazole And Isothizaole Compounds (AREA)

IL11964796A 1995-11-22 1996-11-19 Crystalline modification v of the hydrochloride of (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl}-chroman, its preparation and a pharmaceutical composition containing it IL119647A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE19543478A DE19543478A1 (de)	1995-11-22	1995-11-22	Kristallines Hydrochlorid von {(R)-(-)-2- N-[4-(1,1-Dioxido-3-oxo-2,3-dihydrobenzisothiazol-2-yl)-buytl]-aminomethyl}-chroman

Publications (2)

Publication Number	Publication Date
IL119647A0 IL119647A0 (en)	1997-02-18
IL119647A true IL119647A (en)	1999-12-22

Family

ID=7778081

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL11964796A IL119647A (en)	1995-11-22	1996-11-19	Crystalline modification v of the hydrochloride of (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl}-chroman, its preparation and a pharmaceutical composition containing it

Country Status (32)

Country	Link
US (1)	US5830908A (et)
EP (1)	EP0775704B1 (et)
JP (1)	JPH09143180A (et)
KR (1)	KR970027079A (et)
CN (1)	CN1086703C (et)
AR (1)	AR004961A1 (et)
AT (1)	ATE201872T1 (et)
AU (1)	AU712922B2 (et)
BR (1)	BR9605646A (et)
CA (1)	CA2190700A1 (et)
CZ (1)	CZ289730B6 (et)
DE (2)	DE19543478A1 (et)
DK (1)	DK0775704T3 (et)
EE (1)	EE9600183A (et)
ES (1)	ES2159342T3 (et)
GR (1)	GR3036505T3 (et)
HU (1)	HUP9603237A3 (et)
IL (1)	IL119647A (et)
MX (1)	MX9605741A (et)
MY (1)	MY132473A (et)
NO (1)	NO307340B1 (et)
NZ (1)	NZ299780A (et)
PL (1)	PL317090A1 (et)
PT (1)	PT775704E (et)
RU (1)	RU2181723C2 (et)
SG (1)	SG44989A1 (et)
SI (1)	SI0775704T1 (et)
SK (1)	SK150096A3 (et)
TR (1)	TR199600930A2 (et)
TW (1)	TW449595B (et)
UA (1)	UA45338C2 (et)
ZA (1)	ZA969753B (et)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5854217A (en) *	1992-09-28	1998-12-29	Bearsden Bio, Inc.	Allosteric modulators of the NMDA receptor and their use in the treatment of CNS disorders and enhancement of CNS function
US7407955B2 (en)	2002-08-21	2008-08-05	Boehringer Ingelheim Pharma Gmbh & Co., Kg	8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en)	2004-02-18	2009-03-10	Boehringer Ingelheim International Gmbh	8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de)	2004-11-05	2006-05-11	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de)	2005-07-30	2007-02-08	Boehringer Ingelheim Pharma Gmbh & Co. Kg	8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP2540725A1 (de)	2006-05-04	2013-01-02	Boehringer Ingelheim International GmbH	Polymorphe von 1-((4-Methyl-chinazolin-2-yl)methyl)-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-amino-piperidin-1-yl)xanthin
EP1852108A1 (en)	2006-05-04	2007-11-07	Boehringer Ingelheim Pharma GmbH & Co.KG	DPP IV inhibitor formulations
PE20080251A1 (es)	2006-05-04	2008-04-25	Boehringer Ingelheim Int	Usos de inhibidores de dpp iv
WO2009024542A2 (en) *	2007-08-17	2009-02-26	Boehringer Ingelheim International Gmbh	Purin derivatives for use in the treatment of fab-related diseases
PE20091730A1 (es)	2008-04-03	2009-12-10	Boehringer Ingelheim Int	Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) *	2008-06-03	2010-02-23	Boehringer Ingelheim Int	Tratamiento de nafld
BRPI0916997A2 (pt)	2008-08-06	2020-12-15	Boehringer Ingelheim International Gmbh	Inibidor de dpp-4 e seu uso
UY32030A (es)	2008-08-06	2010-03-26	Boehringer Ingelheim Int	"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
NZ604091A (en) *	2008-08-15	2014-08-29	Boehringer Ingelheim Int	Purin derivatives for use in the treatment of fab-related diseases
CN102149407A (zh)	2008-09-10	2011-08-10	贝林格尔.英格海姆国际有限公司	治疗糖尿病和相关病症的组合疗法
US20200155558A1 (en)	2018-11-20	2020-05-21	Boehringer Ingelheim International Gmbh	Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
CN102256976A (zh)	2008-12-23	2011-11-23	贝林格尔.英格海姆国际有限公司	有机化合物的盐形式
AR074990A1 (es)	2009-01-07	2011-03-02	Boehringer Ingelheim Int	Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
KR20240090632A (ko)	2009-11-27	2024-06-21	베링거 인겔하임 인터내셔날 게엠베하	리나글립틴과 같은 ｄｐｐ－ｉｖ 억제제를 사용한 유전자형 검사된 당뇨병 환자의 치료
CN102946875A (zh)	2010-05-05	2013-02-27	贝林格尔.英格海姆国际有限公司	组合疗法
WO2011161161A1 (en)	2010-06-24	2011-12-29	Boehringer Ingelheim International Gmbh	Diabetes therapy
AR083878A1 (es)	2010-11-15	2013-03-27	Boehringer Ingelheim Int	Terapia antidiabetica vasoprotectora y cardioprotectora, linagliptina, metodo de tratamiento
US8883800B2 (en)	2011-07-15	2014-11-11	Boehringer Ingelheim International Gmbh	Substituted quinazolines, the preparation thereof and the use thereof in pharmaceutical compositions
US9555001B2 (en)	2012-03-07	2017-01-31	Boehringer Ingelheim International Gmbh	Pharmaceutical composition and uses thereof
JP6218811B2 (ja)	2012-05-14	2017-10-25	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｓｉｒｓ及び／又は敗血症の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
JP6224084B2 (ja)	2012-05-14	2017-11-01	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	糸球体上皮細胞関連障害及び／又はネフローゼ症候群の治療に用いるｄｐｐ−４阻害薬としてのキサンチン誘導体
WO2013174767A1 (en)	2012-05-24	2013-11-28	Boehringer Ingelheim International Gmbh	A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
EP3110449B1 (en)	2014-02-28	2023-06-28	Boehringer Ingelheim International GmbH	Medical use of a dpp-4 inhibitor
CN109310697A (zh)	2016-06-10	2019-02-05	勃林格殷格翰国际有限公司	利格列汀和二甲双胍的组合

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4748182A (en) *	1986-03-05	1988-05-31	Merrell Dow Pharmaceuticals Inc.	Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
US5300523A (en) *	1988-07-28	1994-04-05	Bayer Aktiengesellschaft	Substituted aminomethyltetralins and their heterocyclic analogues
DE3901814A1 (de) *	1988-07-28	1990-02-01	Bayer Ag	Substituierte aminomethylzetraline sowie ihre heterocyclischen analoga
DE4138756A1 (de) *	1991-11-26	1993-05-27	Troponwerke Gmbh & Co Kg	Kombination mit neuroprotektiver wirkung

1995
- 1995-11-22 DE DE19543478A patent/DE19543478A1/de not_active Withdrawn
1996
- 1996-10-30 AR ARP960104981A patent/AR004961A1/es unknown
- 1996-11-11 SI SI9630292T patent/SI0775704T1/xx unknown
- 1996-11-11 DK DK96118043T patent/DK0775704T3/da active
- 1996-11-11 EP EP96118043A patent/EP0775704B1/de not_active Expired - Lifetime
- 1996-11-11 ES ES96118043T patent/ES2159342T3/es not_active Expired - Lifetime
- 1996-11-11 PT PT96118043T patent/PT775704E/pt unknown
- 1996-11-11 AT AT96118043T patent/ATE201872T1/de not_active IP Right Cessation
- 1996-11-11 DE DE59607040T patent/DE59607040D1/de not_active Expired - Fee Related
- 1996-11-14 AU AU71772/96A patent/AU712922B2/en not_active Ceased
- 1996-11-18 JP JP8322212A patent/JPH09143180A/ja not_active Withdrawn
- 1996-11-19 CA CA002190700A patent/CA2190700A1/en not_active Abandoned
- 1996-11-19 US US08/752,348 patent/US5830908A/en not_active Expired - Fee Related
- 1996-11-19 NZ NZ299780A patent/NZ299780A/en unknown
- 1996-11-19 IL IL11964796A patent/IL119647A/xx not_active IP Right Cessation
- 1996-11-20 SG SG1996011319A patent/SG44989A1/en unknown
- 1996-11-20 TW TW085114226A patent/TW449595B/zh not_active IP Right Cessation
- 1996-11-20 PL PL96317090A patent/PL317090A1/xx unknown
- 1996-11-21 KR KR1019960056088A patent/KR970027079A/ko not_active Ceased
- 1996-11-21 CZ CZ19963428A patent/CZ289730B6/cs not_active IP Right Cessation
- 1996-11-21 ZA ZA969753A patent/ZA969753B/xx unknown
- 1996-11-21 BR BR9605646A patent/BR9605646A/pt unknown
- 1996-11-21 UA UA96114365A patent/UA45338C2/uk unknown
- 1996-11-21 SK SK1500-96A patent/SK150096A3/sk unknown
- 1996-11-21 NO NO964950A patent/NO307340B1/no not_active IP Right Cessation
- 1996-11-21 MY MYPI96004849A patent/MY132473A/en unknown
- 1996-11-21 MX MX9605741A patent/MX9605741A/es unknown
- 1996-11-21 EE EE9600183A patent/EE9600183A/et unknown
- 1996-11-22 RU RU96122395/04A patent/RU2181723C2/ru active
- 1996-11-22 HU HU9603237A patent/HUP9603237A3/hu unknown
- 1996-11-22 CN CN96114587A patent/CN1086703C/zh not_active Expired - Fee Related
- 1996-11-22 TR TR96/00930A patent/TR199600930A2/xx unknown
2001
- 2001-08-31 GR GR20010401365T patent/GR3036505T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
PL317090A1 (en)	1997-05-26
DK0775704T3 (da)	2001-07-23
AU712922B2 (en)	1999-11-18
NO964950D0 (no)	1996-11-21
SI0775704T1 (en)	2001-08-31
DE19543478A1 (de)	1997-05-28
CN1152574A (zh)	1997-06-25
TW449595B (en)	2001-08-11
ES2159342T3 (es)	2001-10-01
HU9603237D0 (en)	1997-01-28
CZ289730B6 (cs)	2002-03-13
US5830908A (en)	1998-11-03
AR004961A1 (es)	1999-04-07
SK150096A3 (en)	1997-08-06
PT775704E (pt)	2001-09-28
BR9605646A (pt)	1998-08-18
SG44989A1 (en)	1997-12-19
NO307340B1 (no)	2000-03-20
IL119647A0 (en)	1997-02-18
UA45338C2 (uk)	2002-04-15
AU7177296A (en)	1997-05-29
NZ299780A (en)	1998-09-24
RU2181723C2 (ru)	2002-04-27
GR3036505T3 (en)	2001-11-30
HUP9603237A3 (en)	1998-12-28
HUP9603237A2 (hu)	1998-01-28
EP0775704B1 (de)	2001-06-06
CA2190700A1 (en)	1997-05-23
EP0775704A1 (de)	1997-05-28
JPH09143180A (ja)	1997-06-03
CZ342896A3 (en)	1997-06-11
MX9605741A (es)	1997-05-31
CN1086703C (zh)	2002-06-26
EE9600183A (et)	1997-06-16
TR199600930A2 (tr)	1997-06-21
DE59607040D1 (de)	2001-07-12
ATE201872T1 (de)	2001-06-15
NO964950L (no)	1997-05-23
MY132473A (en)	2007-10-31
KR970027079A (ko)	1997-06-24
ZA969753B (en)	1997-03-25

Similar Documents

Publication	Publication Date	Title
IL119647A (en)	1999-12-22	Crystalline modification v of the hydrochloride of (r)-(-)-2-{n-[4-(1,1-dioxido-3-oxo-2,3-dihydro-benzisothiazol-2-yl)-butyl]-aminomethyl}-chroman, its preparation and a pharmaceutical composition containing it
HUT67023A (en)	1995-01-30	Monohydrate of 5-{2-[4-(1,2-benzisothiazol-3-yl)-1-pierazinyl]ethyl}-6-chloro-1,3-dihydro-2h-indole-5-one hydrochloride and pharmaceutical compositions containing that
HRP960558B1 (en)	2002-04-30	New crystalline modifications of cdch, processes for the preparation thereof and pharmaceutical compositions containing them
HUP9900881A3 (en)	2000-09-28	4,5-diaryl oxazole derivatives and pharmaceutical compositions containing them
HUP9601285A3 (en)	2001-04-28	Substituted n-(indole-2-carbonyl)-beta-alaninamides and derivatives and pharmaceutical compositions containing them
IL117349A0 (en)	1996-07-23	N-(3-benyofuranyl) urea-derivatives their preparation and pharmaceutical compositions containing them
CZ129596A3 (en)	1996-11-13	Oxazolidinone derivative, process of its preparation and pharmaceutical composition containing thereof
IL117810A0 (en)	1996-08-04	N-substituted azaheterocyclic carboxylic compounds their preparation and pharmaceutical compositions containing them
HUP0100470A3 (en)	2002-08-28	Oxazolidinone derivatives and pharmaceutical compositions containing them
IL117620A0 (en)	1996-07-23	Heterocyclic compounds processes for the preparation thereof and pharmaceutical compositions containing the same
HUP9801880A3 (en)	1999-08-30	Novel cryptophycins, their use and pharmaceutical compositions containing them
HUP0000960A3 (en)	2001-04-28	Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same
IL117495A0 (en)	1996-07-23	Beta-alanine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
CA2220019A1 (en)	1996-11-07	Pharmaceutical composition containing tiagabine hydrochloride and the process for its preparation
IL117989A (en)	2000-01-31	N-(1-(3,5-bisfluoromethylbenzoyl)-2- benzyl-piperidin-4-YL)-4-oxo-4H-1- benzopyran-2 carboxamides their preparation and pharmaceutical compositions comprising them
HUP9901349A3 (en)	2000-02-28	Oxazolidinone derivatives, their preparation and pharmaceutical compositions containing these compounds
HUP9901212A3 (en)	2000-02-28	N-[2-(3-alkoxy-phenoxy)-ethyl]-dialkylamine derivatives, pharmaceutical compositions containing the same and their use as local anaesthetics
IL117224A (en)	2000-06-29	1,2,5-thiadiazole derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines and antimigraine pharmaceutical compositions comprising them
IT1269508B (it)	1997-04-01	Procedimento per la preparazione di particelle lavorate a secco, particelle lavorate a secco cosi' ottenute e composizioni farmaceutiche contenenti le particelle
IL117315A (en)	2000-07-26	Prokinetic piperidine substituted oxadiazole derivatives their preparation and pharmaceutical compositions containing them
EP0515995A3 (en)	1993-07-21	N-(5-thioxo-l-prolyl)-l-cysteine, derivatives thereof, processes for the preparation thereof and pharmaceutical compositions containing them
HUP0105426A3 (en)	2002-12-28	Derivatives of 3-(2-oxo-[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems and pharmaceutical compositions thereof
IL105774A (en)	1997-01-10	N-(substituted 2-pyridyl)-6-chloro-4-hydroxy-2-methyl-2h-thieno 2, 3-e9-1, 2-thiazine-3-carboxamide, 1, 1-dioxides their preparation and pharmaceutical compositions containing them
HUP0000934A3 (en)	2001-02-28	4-{2-[n-(3-phenoxy-2-hydroxy)propylamino]-ethyl}-anilide derivatives and pharmaceutical compositions thereof
IL133826A0 (en)	2001-04-30	Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl) amino] methyl]amino]benzonitrile and pharmaceutical compositions containing the same

Legal Events

Date	Code	Title
2000-06-01	FF	Patent granted
2000-08-31	KB	Patent renewed
2003-07-31	RH1	Patent not in force